Assessment of Liver Diseases

Assessment of liver diseases thus encircles history, clinical findings, biochemical tests and most usually liver histology which may include patients who have a sign of jaundice and with abnormal liver biochemistry and no significant symptoms. The objective of assessment is to determine the cause of liver damage and also to define its severity and the requirement for therapy. This assessment must be made in two common settings which include the patients who have a clear sign of significant liver disease, usually jaundice and also with the patients who present with abnormal liver biochemistry and no significant symptoms. Then two settings vary in the route and rapidity of the investigations needed. The assessing of liver cells and liver diseases can be done using blood tests, biopsy, fibroscan.

    Related Conference of Assessment of Liver Diseases

    November 25-26, 2025

    21st World Summit on Blockchain Technology

    Amsterdam, Netherlands
    February 04-05, 2026

    18th International Conference on Gynecology

    Rome, Italy
    February 25-26, 2026

    15th International Conference on Herbal Medicine and Acupuncture

    Aix-en-Provence, France
    March 09-10, 2026

    13th World Machine Learning and Deep learning Conference

    Singapore City, Singapore
    March 26-27, 2026

    12th World Congress on Anesthesia and Critical Care

    Amsterdam, Netherlands
    April 20-21, 2026

    47th International Summit on Human Anatomy & Physiology

    Barcelona, Spain
    October 19-20, 2026

    12th World Congress on Medicinal Plants and Marine Drugs

    Aix-en-Provence, France

    Assessment of Liver Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in